About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
3rd Annual Atlanta Precision Oncology Symposium
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
I
CNS Metastases in HER2+ MBC: PFS Data on the Addition of Tucatinib to Capecitabine and Trastuzumab
By
3rd Annual Atlanta Precision Oncology Symposium
FEATURING
Ingrid Mayer
By
3rd Annual Atlanta Precision Oncology Symposium
FEATURING
Ingrid Mayer
592 views
February 9, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
20:00
Exelixis
Child-Pugh Classification and its Role in Treatment Decisions in Pat…
Feat.
P. Gholam
Featured Video
20:25
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
Videos
12:36
3rd Annual Atlanta Precision Oncology Symposium
Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…
Feat.
H. Borghaei
26:48
3rd Annual Atlanta Precision Oncology Symposium
Targeted Therapies for Advanced Urothelial Cancer: Erdafitinib for P…
Feat.
D. Petrylak
13:52
3rd Annual Atlanta Precision Oncology Symposium
Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…
Feat.
H. Borghaei
25:48
3rd Annual Atlanta Precision Oncology Symposium
2021 Expert Discussion on GU Cancers: Should We Use Olaparib Before …
Feat.
E. Antonarakis,
D. Petrylak,
T. Zhang
26:48
3rd Annual Atlanta Precision Oncology Symposium
Treatment of DNA Repair-Deficient Advanced Prostate Cancer
Feat.
E. Antonarakis
26:42
3rd Annual Atlanta Precision Oncology Symposium
2021 Expert Discussion on Advanced NSCLC: Is Osimertinib a Good Sequ…
Feat.
E. Garon,
N. Hanna,
H. Borghaei,
J. Kirkpatrick
23:13
3rd Annual Atlanta Precision Oncology Symposium
Early Detection of Lung Cancer: Molecular Enrichment Strategy
Feat.
J. Kirkpatrick
18:36
3rd Annual Atlanta Precision Oncology Symposium
Selecting Systemic First-Line Treatment in Stage IV NSCLC Without Dr…
Feat.
N. Hanna
20:20
3rd Annual Atlanta Precision Oncology Symposium
2021 Expert Discussion on BC: How to Preoperatively Manage TNBC? How…
Feat.
I. Mayer,
J. Litton,
R. O’Regan
32:45
3rd Annual Atlanta Precision Oncology Symposium
2021 Updates on Systemic Therapy for TNBC: Why Should We Choose Neoa…
Feat.
R. O’Regan
06:49
3rd Annual Atlanta Precision Oncology Symposium
IO for mTNBC: Overview of the Efficacy Data
Feat.
J. Litton
13:30
3rd Annual Atlanta Precision Oncology Symposium
ADCs & Targeted Therapies for Advanced TNBC: Can Sacituzumab Gov…
Feat.
J. Litton
09:52
3rd Annual Atlanta Precision Oncology Symposium
EGFR+ Advanced NSCLC: Should 1L Therapy Include an EGFR Inhibitor Re…
Feat.
E. Garon
15:01
3rd Annual Atlanta Precision Oncology Symposium
EGFR+ Advanced NSCLC: Efficacy Data of TKIs in Combination vs. Alone…
Feat.
E. Garon
05:55
3rd Annual Atlanta Precision Oncology Symposium
Sequence Algorithm for HER2+ Breast Cancer: Does Neratinib + Cape Ha…
Feat.
I. Mayer
05:03
3rd Annual Atlanta Precision Oncology Symposium
CNS Metastases in HER2+ MBC: PFS Data on the Addition of Tucatinib t…
Feat.
I. Mayer
17:47
3rd Annual Atlanta Precision Oncology Symposium
HER2+ MBC Sequencing Algorithm: Surveying the Data for Antibody-Drug…
Feat.
I. Mayer
14:04
3rd Annual Atlanta Precision Oncology Symposium
[PRIVATE] Targeted Therapies for mRCC: Surveying Efficacy Data for I…
Feat.
T. Zhang
17:05
3rd Annual Atlanta Precision Oncology Symposium
[PRIVATE] Targeted Therapies for mRCC: Assessing IMDC Risk Criteria …
Feat.
T. Zhang
08:45
3rd Annual Atlanta Precision Oncology Symposium
Targeting Genetic Mutations in mNSCLC: Clinical Data Overview of RET…
Feat.
H. Dilks